Edgestream Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,317
Closed -$219K 978
2023
Q4
$219K Buy
+7,317
New +$219K 0.02% 774